{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:00:18Z","timestamp":1785351618912,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11606-026-10220-0","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:53:13Z","timestamp":1769629993000},"page":"2882-2889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Race, Ethnicity, and Language Differences in Inpatient Discharge Prescriptions for Alcohol Use Disorder at an Academic Medical Center"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1596-0461","authenticated-orcid":false,"given":"Daniel","family":"Liauw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Brodney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"10220_CR1","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2024.  https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-annual-national-report."},{"key":"10220_CR2","doi-asserted-by":"publisher","unstructured":"McPheeters M, O\u2019Connor EA, Riley S, et al. Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis. JAMA. 2023;330(17):1653. https:\/\/doi.org\/10.1001\/jama.2023.19761","DOI":"10.1001\/jama.2023.19761"},{"key":"10220_CR3","doi-asserted-by":"publisher","unstructured":"Borgundvaag B, Bellolio F, Miles I, et al. Guidelines for reasonable and appropriate care in the emergency department (GRACE-4): alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Acad Emerg Med Off J Soc Acad Emerg Med. 2024;31(5):425-455. https:\/\/doi.org\/10.1111\/acem.14911.","DOI":"10.1111\/acem.14911"},{"key":"10220_CR4","doi-asserted-by":"publisher","unstructured":"Vannier AGL, Shay JES, Fomin V, et al. Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder. JAMA Netw Open. 2022;5(5):e2213014.  https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13014.","DOI":"10.1001\/jamanetworkopen.2022.13014"},{"key":"10220_CR5","doi-asserted-by":"publisher","unstructured":"Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36(1):2-10. https:\/\/doi.org\/10.1093\/alcalc\/36.1.2.","DOI":"10.1093\/alcalc\/36.1.2"},{"key":"10220_CR6","doi-asserted-by":"publisher","unstructured":"Niciu MJ, Arias AJ. Targeted opioid receptor antagonists in the treatment of alcohol use disorders. CNS Drugs. 2013;27(10):777-787.  https:\/\/doi.org\/10.1007\/s40263-013-0096-4.","DOI":"10.1007\/s40263-013-0096-4"},{"key":"10220_CR7","doi-asserted-by":"publisher","unstructured":"Santos GM, Ikeda J, Coffin P, et al. Targeted oral naltrexone for mild to moderate alcohol use disorder among sexual and gender minority men: a randomized trial. Am J Psychiatry. 2022;179(12):915-26.  https:\/\/doi.org\/10.1176\/appi.ajp.20220335.","DOI":"10.1176\/appi.ajp.20220335"},{"key":"10220_CR8","doi-asserted-by":"publisher","unstructured":"R\u00f6sner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Drugs and Alcohol Group, ed. Cochrane Database Syst Rev. Published online September 7, 2010.  https:\/\/doi.org\/10.1002\/14651858.CD004332.pub2.","DOI":"10.1002\/14651858.CD004332.pub2"},{"key":"10220_CR9","doi-asserted-by":"publisher","unstructured":"Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PloS One. 2014;9(2):e87366.https:\/\/doi.org\/10.1371\/journal.pone.0087366.","DOI":"10.1371\/journal.pone.0087366"},{"key":"10220_CR10","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen CH, Pedersen B, T\u00f8nnesen H. The efficacy of disulfiram for the treatment of alcohol use disorder: DISULFIRAM FOR ALCOHOL USE DISORDER. Alcohol Clin Exp Res. 2011;35(10):1749-58.  https:\/\/doi.org\/10.1111\/j.1530-0277.2011.01523.x.","DOI":"10.1111\/j.1530-0277.2011.01523.x"},{"key":"10220_CR11","doi-asserted-by":"publisher","unstructured":"Holt SR. Supervised disulfiram should be considered first-line treatment for alcohol use disorder. J Addict Med. 2024;18(6):614-616. https:\/\/doi.org\/10.1097\/ADM.0000000000001345.","DOI":"10.1097\/ADM.0000000000001345"},{"key":"10220_CR12","doi-asserted-by":"publisher","unstructured":"Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018;320(8):815.  https:\/\/doi.org\/10.1001\/jama.2018.11406.","DOI":"10.1001\/jama.2018.11406"},{"key":"10220_CR13","doi-asserted-by":"publisher","unstructured":"Konrad G, Leong C, Bolton JM, et al. Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: a whole-population cohort study. PloS One. 2021;16(9):e0257025. https:\/\/doi.org\/10.1371\/journal.pone.0257025.","DOI":"10.1371\/journal.pone.0257025"},{"key":"10220_CR14","doi-asserted-by":"publisher","unstructured":"Krist AH, Bradley KA. Addressing alcohol use. N Engl J Med. 2025;392(17):1721-1731. https:\/\/doi.org\/10.1056\/NEJMcp2402121.","DOI":"10.1056\/NEJMcp2402121"},{"key":"10220_CR15","doi-asserted-by":"publisher","unstructured":"Lambert E, Regan S, Wakeman SE. The impact of addiction consultation and medication for opioid or alcohol use disorder on hospital readmission. J Gen Intern Med. Published online January 3, 2025. https:\/\/doi.org\/10.1007\/s11606-024-09301-9.","DOI":"10.1007\/s11606-024-09301-9"},{"key":"10220_CR16","doi-asserted-by":"publisher","unstructured":"Bernstein EY, Baggett TP, Trivedi S, Herzig SJ, Anderson TS. Outcomes after initiation of medications for alcohol use disorder at hospital discharge. JAMA Netw Open. 2024;7(3):e243387. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.3387","DOI":"10.1001\/jamanetworkopen.2024.3387"},{"key":"10220_CR17","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909-16. https:\/\/doi.org\/10.1007\/s11606-017-4077-z","DOI":"10.1007\/s11606-017-4077-z"},{"key":"10220_CR18","doi-asserted-by":"publisher","unstructured":"Karaye IM, Maleki N, Hassan N, Yunusa I. Trends in alcohol-related deaths by Sex in the US, 1999-2020. JAMA Netw Open. 2023;6(7):e2326346. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26346","DOI":"10.1001\/jamanetworkopen.2023.26346"},{"key":"10220_CR19","doi-asserted-by":"publisher","unstructured":"Ayares G, D\u00edaz LA, Fuentes\u2010L\u00f3pez E, et al. Racial and ethnic disparities in the natural history of alcohol\u2010associated liver disease in the United States. Liver Int. 2024;44(10):2822-33. https:\/\/doi.org\/10.1111\/liv.16023","DOI":"10.1111\/liv.16023"},{"key":"10220_CR20","unstructured":"Chartier K, Caetano R. Ethnicity and health disparities in alcohol research. Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol. 2010;33(1-2):152-160."},{"key":"10220_CR21","doi-asserted-by":"publisher","unstructured":"Le P, Rich JJ, Bernstein EY, et al. Disparities in treatment for alcohol use disorder among all of us participants. Am J Psychiatry. 2024;181(11):973-87.  https:\/\/doi.org\/10.1176\/appi.ajp.20230730.","DOI":"10.1176\/appi.ajp.20230730"},{"key":"10220_CR22","doi-asserted-by":"publisher","unstructured":"Williams EC, Gupta S, Rubinsky AD, et al. Variation in receipt of pharmacotherapy for alcohol use disorders across racial\/ethnic groups: A national study in the U.S. Veterans Health Administration. Drug Alcohol Depend. 2017;178:527\u201333.  https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.06.011.","DOI":"10.1016\/j.drugalcdep.2017.06.011"},{"key":"10220_CR23","doi-asserted-by":"publisher","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885.","DOI":"10.1371\/journal.pmed.1001885"},{"key":"10220_CR24","doi-asserted-by":"publisher","unstructured":"Chockalingam L, Burnham EL, Jolley SE. Medication prescribing for alcohol use disorders during alcohol\u2010related encounters in a Colorado regional healthcare system. Alcohol Clin Exp Res. 2022;46(6):1094-1102.  https:\/\/doi.org\/10.1111\/acer.14837.","DOI":"10.1111\/acer.14837"},{"key":"10220_CR25","doi-asserted-by":"publisher","unstructured":"Krimpuri R, Youngs C, Emerman C. Initiation of medication for alcohol use disorder for inpatients with alcohol withdrawal syndromes. J Stud Alcohol Drugs. Published online November 8, 2022:jsad.22\u201300219.  https:\/\/doi.org\/10.15288\/jsad.22-00219.","DOI":"10.15288\/jsad.22-00219"},{"key":"10220_CR26","doi-asserted-by":"publisher","unstructured":"Pinedo M. A current re-examination of racial\/ethnic disparities in the use of substance abuse treatment: do disparities persist? Drug Alcohol Depend. 2019;202:162-167. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.017.","DOI":"10.1016\/j.drugalcdep.2019.05.017"},{"key":"10220_CR27","doi-asserted-by":"publisher","unstructured":"Pinedo M, Villatoro AP. The role of perceived treatment need in explaining racial\/ethnic disparities in the use of substance abuse treatment services. J Subst Abuse Treat. 2020;118:108105. https:\/\/doi.org\/10.1016\/j.jsat.2020.108105.","DOI":"10.1016\/j.jsat.2020.108105"},{"key":"10220_CR28","doi-asserted-by":"publisher","unstructured":"Paradise RK, Bazzi AR, Clarke J, et al. Multilevel factors impacting substance use treatment access, engagement, and racial equity among opioid overdose survivors in Boston, MA. J Gen Intern Med. 2024;39(13):2390-2399. https:\/\/doi.org\/10.1007\/s11606-024-08918-0.","DOI":"10.1007\/s11606-024-08918-0"},{"key":"10220_CR29","doi-asserted-by":"publisher","unstructured":"Ramirez N, Shi K, Yabroff KR, Han X, Fedewa SA, Nogueira LM. Access to care among adults with limited English proficiency. J Gen Intern Med. 2023;38(3):592-599. https:\/\/doi.org\/10.1007\/s11606-022-07690-3.","DOI":"10.1007\/s11606-022-07690-3"},{"key":"10220_CR30","doi-asserted-by":"publisher","unstructured":"Himmelstein J, Himmelstein DU, Woolhandler S, et al. Health care spending and use among Hispanic adults with and without limited English proficiency, 1999-2018. Health Aff Proj Hope. 2021;40(7):1126-1134. https:\/\/doi.org\/10.1377\/hlthaff.2020.02510.","DOI":"10.1377\/hlthaff.2020.02510"},{"key":"10220_CR31","doi-asserted-by":"publisher","unstructured":"Acevedo A, Adams RS, Cook BL, Feltus SR, Panas L, Stewart MT. Disparities in alcohol treatment use at the intersection of race, ethnicity, gender, and insurance. Subst Use Addict J. 2025;46(1):78-89.  https:\/\/doi.org\/10.1177\/29767342241278871.","DOI":"10.1177\/29767342241278871"},{"key":"10220_CR32","doi-asserted-by":"publisher","unstructured":"Delk J, Bensley K, Ye Y, et al. Intersectional disparities in outpatient alcohol treatment completion by gender and race and ethnicity. Alcohol Clin Exp Res. 2024;48(2):389-399. https:\/\/doi.org\/10.1111\/acer.15243.","DOI":"10.1111\/acer.15243"},{"key":"10220_CR33","doi-asserted-by":"publisher","unstructured":"Pinedo M. Missed opportunities by health care providers to reduce racial\/ethnic disparities in the use of alcohol treatment services. Drug Alcohol Depend. 2021;226:108851. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108851.","DOI":"10.1016\/j.drugalcdep.2021.108851"},{"key":"10220_CR34","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Kane M, Powell E, et al. A hospital-wide initiative to redesign substance use disorder care: impact on pharmacotherapy initiation. Subst Abuse. 2021;42(4):767-774. https:\/\/doi.org\/10.1080\/08897077.2020.1846664.","DOI":"10.1080\/08897077.2020.1846664"},{"key":"10220_CR35","doi-asserted-by":"publisher","unstructured":"Bryant AS, Healey JA, Wilkie S, Carten C, Sequist TD, Taveras EM. A health system framework for addressing structural racism: Mass General Brigham\u2019s united against racism initiative. Health Equity. 2023;7(1):533-542. https:\/\/doi.org\/10.1089\/heq.2023.0077.","DOI":"10.1089\/heq.2023.0077"},{"key":"10220_CR36","doi-asserted-by":"publisher","unstructured":"Wilson JD, Altieri Dunn SC, Roy P, Joseph E, Klipp S, Liebschutz J. Inpatient addiction medicine consultation service impact on post-discharge patient mortality: a propensity-matched analysis. J Gen Intern Med. 2022;37(10):2521-2525. https:\/\/doi.org\/10.1007\/s11606-021-07362-8.","DOI":"10.1007\/s11606-021-07362-8"},{"key":"10220_CR37","doi-asserted-by":"publisher","unstructured":"Singh-Tan S, Torres-Lockhart K, Jakubowski A, et al. Addiction consult service and inpatient outcomes among patients with alcohol use disorder. J Gen Intern Med. 2023;38(14):3216-3223. https:\/\/doi.org\/10.1007\/s11606-023-08202-7.","DOI":"10.1007\/s11606-023-08202-7"},{"key":"10220_CR38","doi-asserted-by":"publisher","unstructured":"Haeny AM, Oluwoye O, Cruz R, et al. Drug and alcohol treatment utilization and barriers among Black, American Indian\/Alaskan Native, Latine, Asian\/Pacific Islander\/Native Hawaiian, and White adults: findings from NESARC-III. J Subst Abuse Treat. 2021;131:108569.  https:\/\/doi.org\/10.1016\/j.jsat.2021.108569.","DOI":"10.1016\/j.jsat.2021.108569"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10220-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:37:30Z","timestamp":1785350250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10220"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10220-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}